Literature DB >> 28836702

Results of a 36-year surveillance program for ulcerative colitis-associated neoplasia in the Japanese population.

Junko Kishikawa1, Keisuke Hata1, Shinsuke Kazama1, Hiroyuki Anzai1, Takahide Shinagawa1, Koji Murono1, Manabu Kaneko1, Kazuhito Sasaki1, Koji Yasuda1, Kensuke Otani1, Takeshi Nishikawa1, Toshiaki Tanaka1, Tomomichi Kiyomatsu1, Kazushige Kawai1, Hiroaki Nozawa1, Soichiro Ishihara1, Teppei Morikawa2, Masashi Fukayama2, Toshiaki Watanabe1,3.   

Abstract

BACKGROUND AND AIM: Surveillance colonoscopy has been carried out for patients with long-standing ulcerative colitis who have an increased risk for colorectal cancer. The aim of the present study was to determine the incidence of and the risk factors for neoplasia.
METHODS: We evaluated 289 ulcerative colitis patients who underwent surveillance colonoscopy between January1979 and December 2014. Cumulative incidence of neoplasia and its risk factors were investigated. Clinical stage and overall survival were compared between the surveillance and non-surveillance groups.
RESULTS: Cumulative risk of dysplasia was 3.3%, 12.1%, 21.8%, and 29.1% at 10, 20, 30 and 40 years after the onset of ulcerative colitis, respectively. Cumulative risk of colorectal cancer was 0.7%, 3.2%, 5.2%, and 5.2% at 10, 20, 30 and 40 years from the onset of ulcerative colitis, respectively. Total colitis was a risk factor for neoplasia (P = 0.015; hazard ratio, 2.96).
CONCLUSIONS: Our surveillance colonoscopy program revealed the incidence and risk factors of ulcerative colitis-associated neoplasias in the Japanese population. Total colitis is a risk factor for neoplasia.
© 2017 Japan Gastroenterological Endoscopy Society.

Entities:  

Keywords:  colonoscopy; colorectal cancer; dysplasia; risk factor; ulcerative colitis

Mesh:

Year:  2017        PMID: 28836702     DOI: 10.1111/den.12955

Source DB:  PubMed          Journal:  Dig Endosc        ISSN: 0915-5635            Impact factor:   7.559


  5 in total

1.  Increased Genetic Instability and Accelerated Progression of Colitis-Associated Colorectal Cancer through Intestinal Epithelium-specific Deletion of Klf4.

Authors:  Vincent W Yang; Yang Liu; Julie Kim; Kenneth R Shroyer; Agnieszka B Bialkowska
Journal:  Mol Cancer Res       Date:  2018-08-14       Impact factor: 5.852

2.  Laryngeal Carcinoma in Patients With Inflammatory Bowel Disease: Clinical Outcomes and Risk Factors.

Authors:  Steffi E M van de Ven; Lauranne A A P Derikx; Iris D Nagtegaal; Carla M van Herpen; Robert P Takes; Willem J G Melchers; Marieke Pierik; Tim van den Heuvel; Rob H A Verhoeven; Frank Hoentjen; L H C Nissen
Journal:  Inflamm Bowel Dis       Date:  2020-06-18       Impact factor: 5.325

Review 3.  Management of elderly ulcerative colitis in Japan.

Authors:  Masaaki Higashiyama; Akira Sugita; Kazutaka Koganei; Kenji Wanatabe; Yoko Yokoyama; Motoi Uchino; Masakazu Nagahori; Makoto Naganuma; Shigeki Bamba; Shingo Kato; Ken Takeuchi; Teppei Omori; Tomohisa Takagi; Satohiro Matsumoto; Mitsuo Nagasaka; Shintaro Sagami; Kazuya Kitamura; Takehiko Katsurada; Ken Sugimoto; Noritaka Takatsu; Masayuki Saruta; Toshiyuki Sakurai; Kazuhiro Watanabe; Shiro Nakamura; Yasuo Suzuki; Ryota Hokari
Journal:  J Gastroenterol       Date:  2019-04-20       Impact factor: 7.527

4.  Risk of Colorectal Cancer in Ulcerative Colitis Patients: A Systematic Review and Meta-Analysis.

Authors:  Qing Zhou; Zhao-Feng Shen; Ben-Sheng Wu; Cheng-Biao Xu; Zhong-Qi He; Tuo Chen; Hong-Tao Shang; Chao-Fan Xie; Si-Yi Huang; Yu-Gen Chen; Hai-Bo Chen; Shu-Tang Han
Journal:  Gastroenterol Res Pract       Date:  2019-11-03       Impact factor: 2.260

5.  Accelerated perineural invasion in colitis-associated cancer: A retrospective cohort study.

Authors:  Hiroaki Nozawa; Keisuke Hata; Tetsuo Ushiku; Kazushige Kawai; Toshiaki Tanaka; Yasutaka Shuno; Takeshi Nishikawa; Kazuhito Sasaki; Shigenobu Emoto; Manabu Kaneko; Koji Murono; Hirofumi Sonoda; Soichiro Ishihara
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.